Medical cannabis product approved for epilepsy

Much like investors who have pulled back from the highly anticipated IPOs of 2019, many buyers of cannabis stocks and ETFs may want to think again before they hold out for better times and suffer a series of additional downdrafts. Despite the industry’s long-term prospects, some analysts have been cutting forecasts for cannabis sales and cash flow, expecting the underperformance to continue into next year.

Cannabis ETFs and Stocks May Be Next Shoe to Drop After Failed IPOs

Much like investors who have pulled back from the highly anticipated IPOs of 2019, many buyers of cannabis stocks and ETFs may want to think again before they hold out for better times and suffer a series of additional downdrafts. Despite the industry’s long-term prospects, some analysts have been cutting forecasts for cannabis sales and cash flow, expecting the underperformance to continue into next year.

Why we cover medical cannabis: One employer’s story

The Conference Board of Canada and The Globe and Mail are partnering to explore the relationship between career success and cannabis use. Employers and employees (both recreational and medical cannabis users, as well as non-cannabis users) are invited to participate in this study. (Employees interested in taking the survey can click on this link. Employers interested in taking the survey can click on this link.) The data from these surveys will be aggregated and used to conduct analysis and create a report that will be presented Oct. 15, 2019, at a conference at The Globe and Mail Centre in Toronto.

Big Buddah

Hindukush x Cheese is a unique hybrid combining two of the most appreciated cannabis strains in the modern history of cannabis.

The Hindukush we used to make this strain is the original Hindukush clone first brought to Holland in the late 1970s/early 80s, and is the mother of most Kush strains available today.